Neurological Narratives: A Journey into Women’s Brain Health Research

FHS
March 7, 2024
12:17 pm

This insightful interview explores the disparities in neurological care and the innovative strategies aimed at transforming research and treatment for better, inclusive health outcomes.

Mydecine Receives Management Cease Trade Order | Psychedelic Invest

VANCOUVER, British Columbia, May 2, 2024 (TheNewswire) — Mydecine Innovations Group Inc. (the “Company”) (CSE: MYCO) (FSE: 0NF0) (OTC: MYCOF) (AQSE: MYIG) announces that it has received a temporary

May 3, 2024

EU’s pharma legislative reforms ‘will scare investment away,’ Astellas executive says

Europe is on the brink of wrapping up its first major legal and regulatory reforms for the pharma industry in about two decades, but some

April 2, 2024

Targeted Combination Shows Promise in Metastatic Kidney Cancer

LOUISVILLE, Ky. — More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug combination, which held disease progression at

November 14, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.